By Erica Bartlett, Product Manager Value-based agreements (VBAs), sometimes called outcomes-based agreements, are on the rise. According to Aetna, it is estimated by 2020 that 75-80% of its [...]

Model N had a fantastic visit this year to the Medicaid Drug Rebate Program Summit (MDRP) in Chicago. It is always a welcomed event to catch up with colleagues, learn from our partners, and [...]

For the Model N life science team, the cancellation of the proposed Safe Harbor Rule change wasn’t just a regulatory decision, it meant we needed to revamp our product planning and initiatives [...]

Medtech revenues have never been higher, and are forecast to reach $595 billion worldwide by 2024, reflecting a CAGR of 5.6% between 2017 and 2024.   Model N counts many medtech manufacturers [...]

The Life Sciences industry is evolving at a faster pace than ever before and drug manufacturers are tasked with managing unprecedented frequency, uncertainty, and complexity of reporting [...]